|
BRAND NAME |
GENERIC NAME |
CONDITION |
DOSAGE FORM |
ANTICIPATED LAUNCH |
|
Prialt ® |
Ziconotide Acetate |
Used to manage pain |
Injection |
2024 |
|
Sandostatin Lar ® |
Octreotide Acetate |
Treats diarrhea and flushing caused by cancer and acromegaly |
Injection |
2024 |
|
Ztlido (1.8%) ® |
Lidocaine |
Treats pain |
Patches |
2024 |
|
Gattex ® |
Teduglutide Recombinant |
Treats short bowel syndrome |
Injection |
2024 |
|
Motegrity ® |
Prucalopride Succinate |
Treats constipation |
Tablets |
2024 |
|
Atrovent HFA ® |
Ipratropium Bromide |
Treats intense flare-ups of shortness of breath |
Inhaler |
2024 |
|
Dificid ® |
Fidaxomicin |
Treats C. difficile-associated diarrhea |
Tablets |
2024 |
|
Nuplazid (10mg) ® |
Pimavanserin |
Treats hallucinations and delusions associated with Parkinsons disease |
Capsules |
2024 |
|
Multaq (400mg) ® |
Dronedarone |
Reduces risk of hospitalization for atrial fibrillation |
Tablets |
2024 |
|
Tybost (150mg) ® |
Cobicistat |
Treats HIV-1 infection |
Tablets |
2024 |
|
Lumify (0.025%) ® |
Brimonidine Tartrate Ophthalmic |
Treats redness of the eye due to irritation |
Solution |
2024 |
|
Ingrezza (40, 60, 80mg)® |
Valbenazine |
Treats tardive dyskinesia |
Capsules |
2024 |
|
Cardene ® |
Nicardipine Hydrochloride |
Treats hypertension short term when oral therapy is not feasible |
Injection |
2024 |
|
Promacta (12.5, 25mg)® |
Eltrombopag |
Treats thrombocytopenia and aplastic anemia |
Oral Suspension |
2024 |
|
Descovy ® |
Emtricitabine and Tenofovir Alafenamide |
Treats HIV-1 |
Tablets |
2024 |
|
Timolol Maleate ® |
Timolol Maleate |
Treats elevated intraocular pressure |
Ophthalmic Gel Solution |
2024 |
|
Entresto ® |
Sacubitril and Valsartan |
Treats symptomatic heart failure |
Tablets |
2024 |
|
Halog ® |
Halcinonide |
Treats inflammation and pruritic manifestations of corticosteroid-responsive dermatoses |
Topical Solution |
2024 |
|
Exparel ® |
Bupivacaine Liposome |
Used as an interscalene brachial plexus nerve block |
Injection |
2024 |
|
Nymalize ® |
Nimodipine |
Used for the improvement of neurological outcome in patients with subarachnoid hemorrhage |
Oral solution |
2024 |
|
Olumiant ® |
Baricitinib |
Treats rheumatoid arthritis |
Tablets |
2024 |
|
Rayos (1, 2, 5 mg) ® |
Prednisone |
Treats inflammation of the skin, joints, lungs, and other organs |
Tablets |
2024 |
|
Ibrance® |
Palbociclib |
Used to treat breast cancer |
Cap |
2024 |
|
Teflaro® |
Ceftaroline |
Used to treat bacterial infections |
Injection |
2024 |
|
Edurant® |
Rilpivirine |
Used to treat HIV |
Tab |
2024 |
|
Qtern® |
Dapagliflozin/Saxagliptin |
Used to lower blood sugar in patients with high blood sugar |
Tablet |
2024 |
|
Complera® |
Emtricitabine, Rilpivirine, Tenofovir |
Used to treat HIV |
Tablets |
2024 |
|
Omidria® |
Ketorolac 0.3%/Phenylephrine 1% |
Used during eye surgery & to lower eye pain after eye surgery |
Injection |
2024 |
|
Ofev® |
Nintedanib |
Used to treat idiopathic pulmonary fibrosis or certain other lung problems |
Capsule |
2024 |
|
Isentress® |
Raltegravir Potassium |
Used to treat HIV |
Tablets |
2024 |
|
Atorvaliq® |
Atorvastatin Suspension |
Used to lower bad cholesterol and triglycerides, and raise good cholesterol (HDL) |
Suspension |
2024 |
|
Duavee® |
Bazedoxifene Acetate; Estrogens, Conjugated |
Used to treat low estrogen levels and soft, brittle bones after menopause |
Tablets |
2024 |
|
Jesduvroq® |
Daprodustat |
Used to treat anemia |
Tablets |
2024 |
|
Motpoly XR® |
Lacosamide |
Used to treat seizures |
Capsules |
2024 |
|
Zirgan® |
Ganciclovir |
Used to treat a viral infection of the eyes |
Ophthalmic Gel |
2024 |
|
Inbrija® |
Levodopa |
Used to treat off episodes in people with Parkinsons disease |
Oral Inhalation |
2024 |
|
Xdemvy® |
Lotilaner |
Used to treat a certain eyelid disease caused by mites |
Solution/Drops |
2024 |
|
Opvee® |
Nalmefene |
Used to treat some overdoses |
Nasal Spray |
2024 |
|
Rezzayo® |
Rezafungin |
Used to treat fungal infections |
Powder |
2024 |
|
Filspari® |
Sparsentan |
Used to lower protein in the urine in patients who have kidney disease |
Tablet |
2024 |
|
Hetlioz® |
Tasimelteon |
Used to treat sleep problems |
Oral Suspension |
2024 |
|
Tobi Podhaler® |
Tobramycin |
Used to in people with cystic fibrosis to treat a certain type of bacterial infection |
Inhalation Powder |
2024 |
|
Zavzpret® |
Zavegepant |
Used to treat migraine headaches |
Spray |
2024 |
|
Byetta® |
Exenatide Synthetic |
Used to lower blood sugar |
Injection |
2024 |
|
Paxlovid® |
Nirmatrelvir and Ritonavir |
Used in certain people to treat COVID-19 |
Tablet |
2024 |
|
Inpefa® |
Sotagliflozin |
Used to lower the risk of hospital stays and death because of heart failure |
Tablet |
2024 |
|
Brilinta (60 mg)® |
Ticagrelor |
Used to lower the chance of heart attack, stroke or death |
Tablets |
2024 |
|
Nucynta® |
Tapentadol |
Used to ease pain |
Tablets |
2024 |
|
Nucynta ER® |
Tapentadol Extended-Release |
Used to ease pain |
Tablets |
2024 |
|
Litfulo® |
Ritlecitinib |
Used to treat a type of hair loss called alopecia areata |
Capsules |
2024 |
|
Tyvaso DPI® |
Treprostinil |
Used to treat high blood pressure in the lungs |
Inhalation Powder |
2024 |
|
Qsymia® |
Phentermine/Topiramate extended-release |
Used to help with weight loss in certain people |
Capsule |
December 2024 |
|
Neupro® |
Rotigotine |
Used to treat Parkinsons disease and restless leg syndrome |
Transdermal patch |
2024 |
|
Zoryve® |
Roflumilast |
Used to treat plaque psoriasis |
Cream |
2024 |
|
Miebo® |
Perfluorohexyloctane |
Used to treat dry eyes |
Solution/Drops |
2024 |
|
Abilify® |
Aripiprazole |
Treats schizophrenia and bipolar disorder |
Injection |
2025 |
|
Sancuso® |
Granisetron |
Used to treat upset stomach and throwing up |
Transdermal Patch |
January 22, 2025 |
|
Namzaric® |
Donepezil/Memantine |
Used to treat dementia |
Capsule |
January 2025 |
|
Veltassa® |
Patiromer |
Used to treat high potassium levels |
Powder/Drops |
2025 |
|
Upneeq® |
Oxymetazoline |
Used to treat a drooping eyelid |
Ophthalmic Solution/Drops |
2025 |
|
Auryxia® |
Ferric Citrate |
Used to lower high phosphate levels and to treat anemia |
Tablet |
March 20, 2025 |
|
Jentadueto® |
Linagliptin; Metformin Hydrochloride |
Used to lower blood sugar in patients with diabetes |
Tablet |
May 2, 2025 |
|
Jentadueto XR® |
Linagliptin; Metformin Hydrochloride |
Used to lower blood sugar in patients with diabetes |
Tablet |
May 2, 2025 |
|
Tradjenta® |
Linagliptin |
Used to lower blood sugar in patients with diabetes |
Tablet |
May 2, 2025 |
|
Ravicti® |
Glycerol Phenylbutyrate |
Used to treat urea cycle problems |
Oral Liquid |
July 1, 2025 |
|
Opsumit® |
Macitentan |
Treats high blood pressure in the lungs |
Tablets |
December 5, 2025 |
|
Xeljanz® |
Tofacitinib |
Treats some types of arthritis, ulcerative colitis and ankylosing spondylitis |
Tablets |
December 2025 |
|
Xeljanz XR® |
Tofacitinib |
Treats some types of arthritis, ulcerative colitis and ankylosing spondylitis |
Tablets |
December 2025 |
|
Bridion® |
Sugammadex |
Used to reverse the effects of some drugs |
Solution |
January 2026 |
|
Briviact® |
Brivaracetam |
Used to treat seizures |
Tablets |
February 2026 |
|
*Actual launch dates depend on FDA approvals and may change at any time |
